The Latest in Hematology Times

Melflufen-dex proves active in multi-resistant MM

December 12, 2018

Multiple Myeloma

Lymphodepletion improves efficacy of CAR T cells in HL

December 11, 2018

Fludarabine deemed important for CD30.CAR T-cell therapy

December 11, 2018

MetS after HSCT linked to CV events, second cancers

December 11, 2018

Transplantation

Early switch to dasatinib offers clinical benefit to CML patients

December 10, 2018

Emapalumab found safe, effective in primary HLH

December 9, 2018

Inhibitor can improve symptoms of systemic mastocytosis

December 8, 2018

Cythemias

Algorithm uncovers DS in AML patients on IDH inhibitors

December 7, 2018

Mutation confers resistance to venetoclax in CLL

December 7, 2018

Dasatinib re-challenge feasible as 2nd attempt at TKI discontinuation

December 7, 2018

HU could save millions of lives in Africa, speaker says

December 6, 2018

Triplet demonstrates activity in relapsed/refractory MM

December 6, 2018

Multiple Myeloma

Two-drug combo deemed ‘very promising’ for PMBCL

December 6, 2018

ALL regimens clear disease in kids with MPAL

December 5, 2018

Data support apixaban for cancer-associated VTE, doc says

December 5, 2018

Thrombosis